A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer Article

cited authors

  • Socinski, MA; Ivanova, A; Bakri, K; Wall, J; Baggstrom, MQ; Hensing, TA; Mears, A; Tynan, M; Beaumont, J; Peterman, AH; Niell, HB

authors

Publication Date

  • January 1, 2006

webpage

published in

category

keywords

  • carboplatin
  • non-small cell lung cancer
  • paclitaxel

start page

  • 104

end page

  • 109

volume

  • 17

issue

  • 1